Cargando…
A review of clinical efficacy data supporting emergency use authorization for COVID‐19 therapeutics and lessons for future pandemics
Emergency Use Authorization (EUA) allows the US Food and Drug Administration (FDA) to expedite the availability of therapeutics in the context of a public health emergency. To date, an evidentiary standard for clinical efficacy to support an EUA has not yet been established. This review examines the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538903/ https://www.ncbi.nlm.nih.gov/pubmed/35929015 http://dx.doi.org/10.1111/cts.13384 |